[HTML][HTML] Risk factors for retinopathy and DME in type 2 diabetes—results from the German/Austrian DPV database

HP Hammes, R Welp, HP Kempe, C Wagner, E Siegel… - PloS one, 2015 - journals.plos.org
To assess the prevalence and risk factors for early and severe diabetic retinopathy and
macular edema in a large cohort of patients with type 2 diabetes Retinopathy grading (any …

Comparative efficacy and safety of the duodenal‐jejunal bypass liner in obese patients with type 2 diabetes mellitus: a case control study

K Laubner, N Riedel, K Fink, RW Holl… - Diabetes, Obesity …, 2018 - Wiley Online Library
Aims The duodenal‐jejunal bypass liner (DJBL) is an endoscopic device mimicking surgical
duodenal‐jejunal bypass, and is indicated for the treatment of obesity‐associated type 2 …

Female sex, young age, northern German residence, hypoglycemia and disabling diabetes complications are associated with depressed mood in the WHO-5 …

N Prinz, S Ebner, A Grünerbel, U Henkelüdecke… - Journal of affective …, 2017 - Elsevier
Background Like other mental illnesses, depression is a culturally sensitive topic. Hence,
findings cannot be transferred between countries. We investigated the frequency of …

[HTML][HTML] Renal complications and duration of diabetes: an international comparison in persons with Type 1 diabetes

M Dena, AM Svensson, KE Olofsson, L Young… - Diabetes Therapy, 2021 - Springer
Introduction Renal complications are both a marker of previous suboptimal glycaemic
control and a major risk factor for cardiovascular disease in persons with type 1 diabetes …

Comparative characteristics of patients with type 2 diabetes mellitus treated by bariatric surgery versus medical treatment: a multicentre analysis of 277,862 patients …

K Laubner, N Prinz, J Brückel, A Serwas, M Altmeier… - Obesity surgery, 2018 - Springer
Introduction Bariatric surgery is a well-established treatment option for serious obesity and
concomitant type 2 diabetes mellitus (T2DM). In this analysis, we investigated predictors for …

Which patients from routine care use the new insulin analogue glargine U300 compared to patients with glargine U100: A multicenter analysis of 14,123 patients with …

B Bohn, P Bramlage, C Wagner, M Kaltheuner… - Wiener Medizinische …, 2018 - Springer
Summary Background Glargine U300 (Gla-300) is a further development of glargine U100
(Gla-100). Since 2015, Gla-300 has been available in Germany and Austria. We compared …

Clinical inertia among patients with type 2 diabetes mellitus treated with DPP-4i and/or SGLT-2i

S Lanzinger, SM Schmid, R Welp… - Diabetes Research and …, 2018 - Elsevier
Objectives Failure to intensify treatment of patients with type 2 diabetes (T2D) in a timely
manner is a common challenge. If newer oral anti-diabetic drugs (NOADs) such as …

DIVE/DPV registries: benefits and risks of analog insulin use in individuals 75 years and older with type 2 diabetes mellitus

G van Mark, SR Tittel, R Welp, J Gloyer… - BMJ Open Diabetes …, 2021 - drc.bmj.com
Introduction The aims of this study were to characterize insulin-treated individuals aged≥ 75
years with type 2 diabetes using basal insulin analogs (BIA) or regular insulins (human …

Welche Patienten aus der Routinebetreuung verwenden das neue Insulin-Analogon Glargin U300 im Vergleich zu Patienten mit Glargin U100?

B Bohn, P Bramlage, C Wagner… - Wiener Medizinische …, 2017 - oparu.uni-ulm.de
Hintergrund: Glargin U300 (Gla-300) ist eine Weiterentwicklung von Glargin U100 (Gla-100)
und seit 2015 in Deutschland und Österreich erhältlich. Ziel war es zu untersuchen, wie sich …

269-OR: No BMI Increase during the COVID-Pandemic in Children and Adults with T1D in Three Continents: Joint Analysis of ADDN, T1DX, and DPV Registries

K NARAYAN, M AUZANNEAU, N NOOR… - Diabetes, 2022 - Am Diabetes Assoc
The COVID-pandemic necessitated worldwide lockdowns in 2020, with restrictions on
physical activity and changes in eating habits. We investigated temporal trends in BMI in …